Debra Fraser-Howze to Join OraSure Technologies as Vice President, Government and External Affairs
02 1월 2008 - 10:43PM
Business Wire
OraSure Technologies, Inc. (NASDAQ:OSUR), the market leader in oral
fluid diagnostics, is pleased to announce that Debra Fraser-Howze,
current President/CEO of the National Black Leadership Commission
on AIDS (NBLCA), will join the Company as Vice President,
Government and External Affairs on January 7, 2008. Fraser-Howze
will represent OraSure with government officials regarding the
issues, policies, and laws impacting the Company�s businesses,
including the infectious disease and substance abuse testing
businesses. In addition, she will be responsible for developing
relationships with key opinion leaders in the public and private
sectors, trade associations, non-profit groups, and governmental
staff groups and agencies to build support for OraSure�s policy
positions. Fraser-Howze will report to Douglas A. Michels,
OraSure�s President and CEO. �Debra brings an incredible depth of
experience and leadership in community and public service to
OraSure,� said Michels. �She will most definitely enhance our
Company�s ability to understand and address the critical issues
facing the communities we serve in the fight against HIV/AIDS. With
her diverse talents and expertise, she will be a major contributor
to the future success of our Company on several fronts.�
Fraser-Howze has served as the President/CEO of NBLCA, an
organization which she founded in 1987. The NBLCA conducts policy,
research and advocacy on HIV and AIDS to ensure effective
participation of its leadership in all policy and resource
allocation decisions at the national, state and local levels of
communities of African descent nationwide. NBLCA is now the largest
Black HIV and AIDS non-profit organization of its kind in America.
�I am extremely excited about joining OraSure,� said Fraser-Howze.
�Since the founding of NBLCA more than 20 years ago, OraSure has
been a shining star in our fight against the spread of HIV/AIDS.
The advent of the Company�s oral fluid rapid test technology has
had a significant global impact on the epidemic.� Fraser-Howze has
been widely recognized for more than two decades of global
leadership to communities of color regarding teenage pregnancy,
social welfare, and HIV and AIDS. She advised two U.S. Presidents
while serving on the Presidential Advisory Council on HIV/AIDS from
1995-2001. She was the Vice Chair of the HIV Human Services
Planning Council in New York City and Chaired the National
Institute of Heath�s Public Education Technology Committee. In 2003
she was appointed to the New York City Commission on AIDS. �Debra
and her organization NBLCA has been at the forefront in the fight
against HIV/AIDS in our communities. She is the quintessential
leader and her legacy at NBLCA will live on for many years to
come,� said U.S. Congresswoman Donna M. Christensen, chairwoman of
the Congressional Black Caucus Health Braintrust of which
Fraser-Howze is a member. �It has been an honor to work
side-by-side with Debra in our efforts to fight HIV/AIDS. I look
forward to our continued work together in her new capacity at
OraSure, a company that has clearly demonstrated a strong
commitment to the communities we serve.� Prior to her founding
presidency at NBLCA, Fraser-Howze served as Director of Teenage
Services at the New York Urban League. She was also a Legislative
Assistant to the Honorable Charles B. Rangel (D-NY), United States
Member of Congress, while a National Urban League Fellow.
Fraser-Howze holds a B.A. in Interpersonal Communications from
Hunter College and a Master�s in Public Administration from Baruch
College. About OraSure Technologies OraSure Technologies develops,
manufactures and markets oral fluid specimen collection devices
using proprietary oral fluid technologies, diagnostic products
including immunoassays and other in vitro diagnostic tests, and
other medical devices. These products are sold in the United States
as well as internationally to various clinical laboratories,
hospitals, clinics, community-based organizations and other public
health organizations, distributors, government agencies,
physicians� offices, and commercial and industrial entities.
OraSure Technologies is the leading supplier of oral-fluid
collection devices and in vitro diagnostic assays to the
employment, criminal justice, drug treatment, life insurance and
public health markets for the detection of abused drugs and the
antibodies to HIV. Based in Bethlehem, Pa., the company develops,
manufactures and markets oral specimen collection devices, in vitro
diagnostic tests, and other medical devices. For more information
on the Company, please go to www.orasure.com.
OraSure Technologies (NASDAQ:OSUR)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
OraSure Technologies (NASDAQ:OSUR)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024